[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7822 Introduced in House (IH)]
<DOC>
117th CONGRESS
2d Session
H. R. 7822
To allow for duty-free importation and sale of infant formula that is
lawfully marketed as such in its country of origin, and for other
purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
May 18, 2022
Mr. Green of Tennessee (for himself, Mr. Davidson, Mr. Calvert, and Mr.
Hill) introduced the following bill; which was referred to the
Committee on Ways and Means, and in addition to the Committee on Energy
and Commerce, for a period to be subsequently determined by the
Speaker, in each case for consideration of such provisions as fall
within the jurisdiction of the committee concerned
_______________________________________________________________________
A BILL
To allow for duty-free importation and sale of infant formula that is
lawfully marketed as such in its country of origin, and for other
purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Baby Formula Emergency Act''.
SEC. 2. REMOVAL OF LIMITATIONS ON IMPORTATION.
(a) In General.--Upon a determination by the President that there
is a shortage or potential shortage of the supply of infant formula (as
defined in section 201(z) of the Federal Food, Drug, and Cosmetic Act
(21 U.S.C. 321(z))) in the United States, the President may,
notwithstanding any provision of Federal law, suspend any duty imposed
with respect to the importation of any article of infant formula that
meets the criteria specified in subsection (b) on or before the date on
which the President submits the notification described in the second
sentence of subsection (c).
(b) Criteria for Importation.--Notwithstanding any provision of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.), or any
other provision of Federal law, the President may allow, without
restrictions, the production, manufacture, distribution, marketing,
prescribing, sale, or dispensing of any infant formula during the
period in which a shortage or potential shortage, as determined under
subsection (a) exists, if--
(1)(A) the manufacturer of such infant formula certifies to
the Commissioner of Food and Drugs that the infant formula
meets the nutrition requirements under section 412(i) of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 350a(i)); or
(B) the infant formula is lawfully marketed as infant
formula in its country of origin;
(2) the United States has not imposed sanctions with
respect to the actions of the government of the country of
origin of such infant formula, including a ban on the
importation of some or all products of such country as a result
of such actions;
(3) the United States has not imposed any sanctions with
respect to the manufacturer of such infant formula (including
by listing such manufacturer on the List of Specially
Designated Nationals and Blocked Persons maintained by the
Office of Foreign Assets Control of the Department of the
Treasury); and
(4) the Commissioner of Food and Drugs has not determined
that such infant formula is unsafe.
(c) Congressional Notification.--Upon a determination referred to
in subsection (a) with respect to a shortage or potential shortage of
the supply of infant formula, the President shall notify the Committee
on Energy and Commerce and the Committee on Ways and Means of the House
of Representatives and the Committee on Health, Education, Labor and
Pensions and the Committee on Finance of the Senate of such
determination. The President shall notify such committees upon any
determination that the shortage referred to in such subsection no
longer exists.
<all>